Advertisement

Topics

Positive Phase Ib Data For NewLink Genetics??? IDO Pathway Inhibitor, Indoximod, In Combination With Chemotherapy For Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Presented At The European Hematology Association Congress In Madrid, Spain

20:00 EDT 22 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Positive Phase Ib Data For NewLink Genetics??? IDO Pathway Inhibitor, Indoximod, In Combination With Chemotherapy For Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Presented At The European Hematology Association Congress In Madrid, Spain

NEXT ARTICLE

More From BioPortfolio on "Positive Phase Ib Data For NewLink Genetics??? IDO Pathway Inhibitor, Indoximod, In Combination With Chemotherapy For Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Presented At The European Hematology Association Congress In Madrid, Spain"

Advertisement
Quick Search
Advertisement
Advertisement